MedTrace Logo

The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients

NCT00292279 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 206

Last updated 2008-05-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate clinical safety and effect of Omega-3 fat oil emulsion on outcome in post-operative cancer patients.

Conditions

  • Carcinoma Surgery
  • Parenteral Nutrition
  • Post-Operative Hospital Stay

Interventions

DRUG

Omega-3 fish oil emulsion (Omegaven )

Patients of the treatment group received 0.2 g fish oil (10% Omegaven, Fresenius Kabi, Bad Homburg, Germany) and 1.0 g soy bean oil per kg BW per day

DRUG

long-chain triglyceride

the control group received 1.2 g soy bean oil (Intralipid, Sino-Swed,Wuxi,China)

Sponsors & Collaborators

  • Sino-Swed Pharmaceutical Corporation

    lead INDUSTRY

Principal Investigators

  • Zhu-ming Jiang, FACS · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2003-11-30
Completion
2004-02-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00292279 on ClinicalTrials.gov